Literature DB >> 22409817

Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Masayuki Haruta1, Yasuhito Arai, Naoki Watanabe, Yuiko Fujiwara, Shohei Honda, Junjiro Ohshima, Fumio Kasai, Hisaya Nakadate, Hiroshi Horie, Hajime Okita, Jun-Ichi Hata, Masahiro Fukuzawa, Yasuhiko Kaneko.   

Abstract

Epidemiological studies show that the incidence of Wilms tumor (WT) in East-Asian children is half of that in Caucasian children. Abnormalities of WT1, CTNNB1, WTX, and IGF2 were reported to be involved in Wilms tumorigenesis in Caucasians, although none of the studies simultaneously evaluated the four genes. WTX forms the β-catenin degradation complex; however, the relationship between WTX abnormality and CTNNB1 mutation was uncertain in WTs. We examined abnormalities of the four genes in 114 Japanese with WTs to clarify the relationship between genetic and epigenetic factors and the incidence of WTs. We found that abnormalities of WTX and CTNNB1 were mutually exclusive, and that although CTNNB1 mutation was frequent in WTs with WT1 abnormality, but rare in WTs without, the incidences of WTX abnormality were similar between WTs with or without WT1 abnormality. These findings were consistent with those reported in Caucasian populations, and indicate multiple roles of WTX abnormality. Abnormalities of WT1, WTX and CTNNB1, and loss of IGF2 imprinting (LOI) were detected in 31.6%, 22.8%, 26.3%, and 21.1% of the 114 WTs, respectively. When we selected 101 sporadic WTs, the incidences of WT1, CTNNB1, or WTX abnormality were generally comparable between the two populations, whereas the incidence of IGF2 LOI was lower in Japanese than that of IGF2 LOI reported in Caucasians (P = 0.04). This is the first comprehensive study of the four genes, and the results supported the hypothesis that the lower incidence of IGF2 LOI contributes to the lower incidence of WTs in Japanese children.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409817      PMCID: PMC7685077          DOI: 10.1111/j.1349-7006.2012.02269.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  31 in total

1.  PCR amplification of chromosome-specific alpha satellite DNA: definition of centromeric STS markers and polymorphic analysis.

Authors:  P E Warburton; G M Greig; T Haaf; H F Willard
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

2.  Epigenetics--a science of heritable biological adaptation.

Authors:  Sherin U Devaskar; Santanu Raychaudhuri
Journal:  Pediatr Res       Date:  2007-05       Impact factor: 3.756

3.  Frequent association of beta-catenin and WT1 mutations in Wilms tumors.

Authors:  S Maiti; R Alam; C I Amos; V Huff
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

4.  Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.

Authors:  Eric Yuan; Chi-Ming Li; Darrell J Yamashiro; Jessica Kandel; Harshwardhan Thaker; Vundavalli V Murty; Benjamin Tycko
Journal:  Mol Cancer Res       Date:  2005-09       Impact factor: 5.852

5.  Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.

Authors:  Naoki Watanabe; Hisaya Nakadate; Masayuki Haruta; Waka Sugawara; Fumiaki Sasaki; Yukiko Tsunematsu; Atsushi Kikuta; Masahiro Fukuzawa; Hajime Okita; Jun-ichi Hata; Hidenobu Soejima; Yasuhiko Kaneko
Journal:  Genes Chromosomes Cancer       Date:  2006-06       Impact factor: 5.006

6.  Epigenetic differences between Wilms' tumours in white and east-Asian children.

Authors:  Ryuji Fukuzawa; Norman E Breslow; Ian M Morison; Patrick Dwyer; Takeshi Kusafuka; Yasutsugu Kobayashi; David M Becroft; J Bruce Beckwith; Elizabeth J Perlman; Anthony E Reeve
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

7.  Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.

Authors:  Masayuki Haruta; Yasuhito Arai; Waka Sugawara; Naoki Watanabe; Shohei Honda; Junjiro Ohshima; Hidenobu Soejima; Hisaya Nakadate; Hajime Okita; Jun-ichi Hata; Masahiro Fukuzawa; Yasuhiko Kaneko
Journal:  Genes Chromosomes Cancer       Date:  2008-08       Impact factor: 5.006

8.  Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.

Authors:  D Perotti; B Gamba; M Sardella; F Spreafico; M Terenziani; P Collini; A Pession; M Nantron; F Fossati-Bellani; P Radice
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

9.  Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.

Authors:  Flavia Cerrato; Angela Sparago; Gaetano Verde; Agostina De Crescenzo; Valentina Citro; Maria Vittoria Cubellis; Maria Michela Rinaldi; Luigi Boccuto; Giovanni Neri; Cinzia Magnani; Paolo D'Angelo; Paola Collini; Daniela Perotti; Gianfranco Sebastio; Eamonn R Maher; Andrea Riccio
Journal:  Hum Mol Genet       Date:  2008-02-01       Impact factor: 6.150

10.  Childhood cancer and ethnic group in Britain: a United Kingdom children's Cancer Study Group (UKCCSG) study.

Authors:  C A Stiller; P A McKinney; K J Bunch; C C Bailey; I J Lewis
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

View more
  8 in total

1.  Social and biological factors influencing the outcomes of children with Wilms tumors in Kenya and other Sub-Saharan countries.

Authors:  Kazuko Kumon; Yasuhiko Kaneko
Journal:  Transl Pediatr       Date:  2014-01

2.  A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.

Authors:  Y Kaneko; H Okita; M Haruta; Y Arai; T Oue; Y Tanaka; H Horie; S Hinotsu; T Koshinaga; A Yoneda; Y Ohtsuka; T Taguchi; M Fukuzawa
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

Review 3.  Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review.

Authors:  Changkai Deng; Rong Dai; Xuliang Li; Feng Liu
Journal:  Cancer Sci       Date:  2016-03-18       Impact factor: 6.716

4.  Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).

Authors:  Kayo Nakata; Yuri Ito; Winnie Magadi; Audrey Bonaventure; Charles A Stiller; Kota Katanoda; Tomohiro Matsuda; Isao Miyashiro; Kathy Pritchard-Jones; Bernard Rachet
Journal:  Cancer Sci       Date:  2017-12-26       Impact factor: 6.716

5.  Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome.

Authors:  Masayuki Haruta; Yasuhito Arai; Hajime Okita; Yukichi Tanaka; Tetsuya Takimoto; Ryuichi P Sugino; Yasuhiro Yamada; Takehiko Kamijo; Takaharu Oue; Masahiro Fukuzawa; Tsugumichi Koshinaga; Yasuhiko Kaneko
Journal:  Neoplasia       Date:  2018-12-06       Impact factor: 5.715

6.  Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.

Authors:  Janna A Hol; Roland P Kuiper; Freerk van Dijk; Esmé Waanders; Sophie E van Peer; Marco J Koudijs; Reno Bladergroen; Simon V van Reijmersdal; Lionel M Morgado; Jet Bliek; Maria Paola Lombardi; Saskia Hopman; Jarno Drost; Ronald R de Krijger; Marry M van den Heuvel-Eibrink; Marjolijn C J Jongmans
Journal:  J Clin Oncol       Date:  2022-03-01       Impact factor: 50.717

Review 7.  Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future Directions.

Authors:  Till-Martin Theilen; Yannick Braun; Konrad Bochennek; Udo Rolle; Henning C Fiegel; Florian Friedmacher
Journal:  Front Pediatr       Date:  2022-07-14       Impact factor: 3.569

8.  Incidence of childhood renal tumours: An international population-based study.

Authors:  Kayo Nakata; Murielle Colombet; Charles A Stiller; Kathy Pritchard-Jones; Eva Steliarova-Foucher
Journal:  Int J Cancer       Date:  2020-07-22       Impact factor: 7.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.